CORC

在结果中检索

CORC

浏览/检索结果: 共24条，第1-10条 帮助

已选(0)清除 条数/页：   排序方式：
Systematic review and meta-analysis of prevalence of dermatological toxicities associated with vemurafenib treatment in patients with melanoma 期刊论文
CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2019, 卷号: 44, 期号: 3
作者:  Chen, P.;  Chen, F.;  Zhou, B.
收藏  |  浏览/下载：1/0  |  提交时间：2019/12/05
Resistance mechanism of the oncogenic beta 3-alpha C deletion mutation in BRAF kinase to dabrafenib and vemurafenib revealed by molecular dynamics simulations and binding free energy calculations 期刊论文
CHEMICAL BIOLOGY & DRUG DESIGN, 2019, 卷号: 93, 期号: 2, 页码: 177-187
作者:  Niu, Yuzhen;  Zhang, Yan;  Yao, Xiaojun
收藏  |  浏览/下载：4/0  |  提交时间：2019/12/11
Signal transducer and activator of transcription 3 inhibition enhances vemurafenib sensitivity in colon cancers harboring the BRAF mutation 期刊论文
Journal of Cellular Biochemistry, 2019, 卷号: Vol.120 No.4, 页码: 5315-5325
作者:  Kai Wang;  Yanrong Li;  Na Song;  Xiaofang Che;  Kezuo Hou
收藏  |  浏览/下载：7/0  |  提交时间：2019/12/17
Acquired and intrinsic resistance to vemurafenib in BRAF(v600e)-driven melanoma brain metastases 会议论文
Annual Meeting of the American-Association-for-Cancer-Research (AACR), MAR 29-APR 03, 2019
作者:  de Gooijer, Mark C.;  Zhang, Ping;  Buil, Levi C.;  Freriks, Stephan;  Li, Gang
收藏  |  浏览/下载：5/0  |  提交时间：2019/12/31
Rafoxanide, an organohalogen drug, triggers apoptosis and cell cycle arrest in multiple myeloma by enhancing DNA damage responses and suppressing the p38 MAPK pathway 期刊论文
Cancer letters, 2018, 卷号: 444, 页码: 45-59
作者:  Xiao, Wenqin;  Xu, Zhijian;  Chang, Shuaikang;  Li, Bo;  Yu, Dandan
收藏  |  浏览/下载：98/0  |  提交时间：2019/01/08
Identification of recurrent USP48 and BRAF mutations in Cushing's disease 期刊论文
NATURE COMMUNICATIONS, 2018, 卷号: 9
作者:  Chen, Jianhua;  Jian, Xuemin;  Deng, Siyu;  Ma, Zengyi;  Shou, Xuefei
收藏  |  浏览/下载：117/0  |  提交时间：2019/01/08
Effects of PHA-665752 and vemurafenib combination treatment on in vitro and murine xenograft growth of human colorectal cancer cells with BRAFV600E mutations. 期刊论文
Oncol Lett, 2018, 卷号: Vol.15 No.3, 页码: 3904-3910
作者:  Zhi J;  Li Z;  Lv J;  Feng B;  Yang D
收藏  |  浏览/下载：4/0  |  提交时间：2019/03/26
Identification of recurrent USP48 and BRAF mutations in Cushing's disease 期刊论文
NATURE COMMUNICATIONS, 2018, 卷号: 9, 期号: 1, 页码: 3171
作者:  Chen, Jianhua;  Jian, Xuemin;  Song, Zhijian;  Li, Zhiqiang;  Zhou, Juan
收藏  |  浏览/下载：74/0  |  提交时间：2019/04/28
The BET-bromodomain inhibitor JQ1 mitigates vemurafenib drug resistance in melanoma 期刊论文
MELANOMA RESEARCH, 2018, 卷号: 28, 期号: 6, 页码: 521-526
作者:  Zhao, Bei;  Cheng, Xiankui;  Zhou, Xiyuan
收藏  |  浏览/下载：5/0  |  提交时间：2019/12/11
Docking-based structural splicing and reassembly strategy to develop novel deazapurine derivatives as potent B-Raf(V600E) inhibitors 期刊论文
ACTA PHARMACOLOGICA SINICA, 2017, 卷号: 38, 期号: 7, 页码: 1059-1068
作者:  Wang, Gui-min;  Wang, Xiang;  Zhu, Jian-ming;  Guo, Bin-bin;  Yang, Zhuo
收藏  |  浏览/下载：17/0  |  提交时间：2019/01/08

©版权所有 ©2017 CSpace - Powered by CSpace